Publication | Closed Access

Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study

Surgical OncologyMedicineCancer ManagementClinical TrialsGynecologyIntergroup StudyAdjuvant Intraperitoneal Alpha-interferonPrimary SurgeryCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian CancerHealth Sciences